Members |
targetComponentId |
Postmortem examination NOS |
Postmortem examination |
post mortem-røntgenundersøgelse |
Postmortem plain X-ray (procedure) |
Post mortem-røntgenundersøgelse - hjernen |
Postmortem plain X-ray of brain |
Post mortem-røntgenundersøgelse - hjertet |
Postmortem plain X-ray of heart |
post mortem-røntgenundersøgelse - knoglerne |
Postmortem plain X-ray of skeletal system (procedure) |
post mortem-røntgenundersøgelse - kraniet |
Postmortem plain X-ray of bone of cranium (procedure) |
post mortem-røntgenundersøgelse af bløddele |
Postmortem plain X-ray of soft tissue |
Post mortem-røntgenundersøgelse - tænder |
Postmortem plain X-ray of teeth |
post mortem-røntgenundersøgelse - hele kroppen |
Postmortem plain X-ray of entire body |
Postmortem radiology |
Postmortem plain X-ray (procedure) |
Postmortem radiology - brain |
Postmortem plain X-ray of brain |
Postmortem radiology - heart |
Postmortem plain X-ray of heart |
Postmortem radiology - skeleton |
Postmortem plain X-ray of skeletal system (procedure) |
Postmortem radiology - skull |
Postmortem plain X-ray of bone of cranium (procedure) |
Postmortem radiology - soft tissue |
Postmortem plain X-ray of soft tissue |
Postmortem radiology - teeth |
Postmortem plain X-ray of teeth |
Postmortem radiology - whole body |
Postmortem plain X-ray of entire body |
Postmortem radiology NOS |
Postmortem plain X-ray (procedure) |
Postmortem radiology NOS |
Postmortem plain X-ray (procedure) |
Postmortem skeletal survey using radiographic imaging |
Postmortem plain X-ray skeletal survey |
Postnasal space X-ray |
Plain X-ray of nasopharynx (procedure) |
Postnasal space X-ray |
Plain X-ray of nasopharynx (procedure) |
postnatal anti-D-profylakse afslået |
Administration of human anti-D immunoglobulin declined |
Postnatal care NOS |
Postnatal care status |
Postnatal care NOS |
Postnatal care status |
Postnatale data |
Puerperium observable |
Postnatal visit NOS |
Postnatal visit status |
Postnatal visit NOS |
Postnatal visit status |
Postoperativt kataraktsyndrom |
Cystoid macular oedema following cataract surgery |
postoperativ cellulit i operationssår |
Postoperative wound cellulitis |
Postoperativ kolangiografi |
Postoperative fluoroscopic cholangiography with contrast (procedure) |
Postoperative cholangiography |
Postoperative fluoroscopic cholangiography with contrast (procedure) |
Postoperative cholangiography |
Postoperative fluoroscopic cholangiography with contrast (procedure) |
Postoperative myocardial infarction, unspecified |
Postoperative myocardial infarction |
Postoperativt myokardieinfarkt, uspecificeret |
Postoperative myocardial infarction |
postoperativ perkutan fjernelse af sten i galdegang vha. radiologisk vejledning |
Percutaneous removal of calculus from bile duct using fluoroscopic guidance (procedure) |
postoperative procedurer |
Postoperative procedure (procedure) |
Postoperative pulmonary edema |
Postoperative pulmonary edema |
Postoperative status epilepticus |
An abnormally prolonged continuous epileptic seizure or cluster of epileptic seizures in which the individual does not return to normal between seizures. The definition of abnormal duration varies based on seizure type. |
Postoperativt transmuralt myokardieinfarkt med andre lokalisationer |
Postoperative myocardial infarction |
Postoperative transmural myocardial infarction of other sites |
Postoperative myocardial infarction |
Postoperativt transmuralt myokardieinfarkt uden specificeret lokalisation |
Postoperative myocardial infarction |
Postoperative transmural myocardial infarction of unspecified site |
Postoperative myocardial infarction |
Post partum-koagulationsdefekter, ikke nærmere specificeret |
Postpartum coagulation defects |
Post partum-koagulationsdefekter, uspecificeret |
Postpartum coagulation defects |
Post partum-koagulationsdefekter med postnatalt problem |
Postpartum coagulation defects |
Postpartum haemorrhage NOS |
Postpartum hemorrhage |
Post partum-blødning, ikke nærmere specificeret |
Postpartum hemorrhage |
post partum-risiko |
At increased risk for postpartum disorder (finding) |
intraabdominal sepsis efter indgreb |
Intra-abdominal infection following surgical procedure |
Posttraumatic wound infection, NEC |
Post-traumatic wound infection |
Postural proteinuria |
Orthostatic proteinuria |
kalium 6,5 mmol brusetablet |
Potassium only product in oral dose form |
allergi over for kalium |
Propensity to adverse reaction to potassium (finding) |
kaliumhydrogenkarbonat 1,39 g + citronsyre 1,14 g opløselig tablet |
Citric acid and potassium bicarbonate only product in oral dose form |
kaliumchlorid 10 % injektionsvæske, opløsning, ampul |
Product containing precisely potassium chloride 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
kaliumchlorid 10 mækv tablet med modificeret udløsning |
Product containing only potassium chloride in oral dose form (medicinal product form) |
Potassium chloride 10meq prolonged-release oral tablet |
Product containing only potassium chloride in oral dose form (medicinal product form) |
kaliumchlorid 10 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 500 ml |
Anhydrous glucose 40 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
kaliumchlorid 10 mmol/glucose 5 %/natriumchlorid 0,45 % infusionsvæske, opløsning, pose a 500 ml |
Product containing precisely anhydrous glucose 50 milligram/1 milliliter and potassium chloride 1.5 milligram/1 milliliter and sodium chloride 4.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
kaliumchlorid 10 mmol/glucose 5 % infusionsvæske, opløsning, pose a 500 ml |
Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL solution for injection |
kaliumchlorid 10 mmol/natriumchlorid 0,9 % infusionsvæske, opløsning, pose a 500 ml |
Product containing precisely potassium chloride 1.5 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Potassium chloride 1500mg |
Product containing precisely potassium chloride 1.5 gram/1 each conventional release oral tablet (clinical drug) |
kaliumchlorid 15 mækv granulat |
Potassium chloride only product |
kaliumchlorid 15 mækv/pakke |
Potassium chloride only product |
kaliumchlorid 1 g/5 ml opløsning |
Potassium chloride only product |
kaliumchlorid 1 g/ml opløsning |
Product containing precisely potassium chloride 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
kaliumchlorid 20 % injektionsvæske, opløsning, ampul |
Potassium chloride 200 mg/mL solution for injection |
kaliumchlorid 20 % opløsning |
Potassium chloride only product |
kaliumchlorid 20 mækv pulver |
Product containing precisely potassium chloride 1.5 gram/1 sachet powder for conventional release oral solution (clinical drug) |
Potassium chloride 20meq/15m solution |
Product containing precisely potassium chloride 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
kaliumchlorid 20 mækv/15 ml opløsning |
Product containing precisely potassium chloride 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
kaliumchlorid 20 mækv/pakke |
Potassium chloride only product |
kaliumchlorid 20 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 1 l |
Anhydrous glucose 40 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
kaliumchlorid 20 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 500 ml |
Anhydrous glucose 40 mg/mL and potassium chloride 3 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
kaliumchlorid 20 mmol/glucose 5 % infusionsvæske, opløsning, pose a 1 l |
Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL solution for injection |
kaliumchlorid 20 mmol/glucose 5 % infusionsvæske, opløsning, pose a 500 ml |
Anhydrous glucose 50 mg/mL and potassium chloride 3 mg/mL solution for injection |
kaliumchlorid 20 mmol/natriumchlorid 0,9 % infusionsvæske, opløsning, pose a 1 l |
Product containing precisely potassium chloride 1.5 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug) |
kaliumchlorid 20 mmol/natriumklorid 0,9 % infusionsvæske, opløsning, pose a 500 ml |
Product containing precisely potassium chloride 3 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug) |
kaliumchlorid 27 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 1 l |
Anhydrous glucose 40 mg/mL and potassium chloride 2 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
kaliumchlorid 27 mmol/glucose 5 % infusionsvæske, opløsning, pose a 1 l |
Anhydrous glucose 50 mg/mL and potassium chloride 2 mg/mL solution for injection |
kaliumchlorid 27 mmol + natriumchlorid 0,9 % infusionsvæske, opløsning i pose a 1 l |
Product containing precisely potassium chloride 2 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug) |
kaliumchlorid 40 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 1 l |
Anhydrous glucose 40 mg/mL and potassium chloride 3 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
kaliumchlorid 40 mmol/glucose 5 % infusionsvæske, opløsning, pose a 1 l |
Anhydrous glucose 50 mg/mL and potassium chloride 3 mg/mL solution for injection |
kaliumchlorid 40 mmol/natriumchlorid 0,9 % infusionsvæske, opløsning, pose a 1 l |
Product containing precisely potassium chloride 3 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for injection (clinical drug) |
kaliumchlorid 7,5 % syrup |
Product containing only potassium chloride in oral dose form (medicinal product form) |
stærk kaliumchlorid 15 % injektionsvæske, opløsning, ampul |
Product containing only potassium chloride in parenteral dose form (medicinal product form) |
kaliumcitrat 12 g/10 ml koncentreret mikstur |
Product containing only potassium citrate in oral dose form (medicinal product form) |
Potassium citrate 12g/10mL conventional release oral solution |
Product containing only potassium citrate in oral dose form (medicinal product form) |
kaliumcitrat 3 g brev granulat |
Product containing only potassium citrate in oral dose form (medicinal product form) |
bivirkning af kaliumclorazepat |
Adverse reaction to clorazepate |
kaliumglukonat 20 mækv/15 ml eliksir |
Product containing precisely potassium gluconate 312 milligram/1 milliliter conventional release oral solution (clinical drug) |
Potassium permanganate 400mg tablet for conventional release cutaneous solution |
Product containing permanganic acid in cutaneous dose form (medicinal product form) |
kaliumpermanganat 400 mg tablet til opløsning |
Product containing permanganic acid in cutaneous dose form (medicinal product form) |
kaliumphosphat 2 mmol/ml injektionsvæske, opløsning, ampul a 10 ml |
Product containing precisely monobasic potassium phosphate 136 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Kaliumtilskud |
Potassium supplement (substance) |
Potassium-sparing diuretic product (product) |
Potassium-sparing diuretic (substance) |
Potato - dietary |
Potato (substance) |
Potentiel infektionskontakt |
Exposure to organism (event) |
Potential infectious contact |
Exposure to organism (event) |
Potential infectious contact |
Exposure to organism (event) |